Fig. 3From: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trialsThe scenario II of same effect across all seven AEs with safety issues under various increasing incidence rate as dosage increases for eight arms. (The dashed line is the expected incidence rate for each AE)Back to article page